Disruption of α-actinin-integrin interactions at focal adhesions renders osteoblasts susceptible to apoptosis

American Journal of Physiology - Cell Physiology

Volumn 291, Issue 5, 2006, Pages

  Triplett, Jason W ^a   Pavalko, Fredrick M ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Cytoskeleton; Nuclear factor B; Survival; Tumor necrosis factor

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; ALPHA ACTIN; ALPHA INTEGRIN; CASPASE 3; GREEN FLUORESCENT PROTEIN; HISTONE H2A; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEIN KINASE B; VINCULIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; FOCAL ADHESION; IMMUNOFLUORESCENCE; MORPHOMETRICS; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT;

ACTININ; ACTINS; ANIMALS; APOPTOSIS; CELL SURVIVAL; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FOCAL ADHESIONS; HUMANS; INTEGRINS; MICE; MUTANT PROTEINS; NF-KAPPA B; OSTEOBLASTS; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RECEPTORS, CELL SURFACE; RECOMBINANT FUSION PROTEINS; STRESS FIBERS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33751091524     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00113.2006     Document Type: Article

References (56)

1. Amaravadi R and Thompson CB. The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest 115: 2618-2624, 2005.
2. Attwell S, Roskelley C, and Dedhar S. The integrin-linked kinase (ILK) suppresses anoikis. Oncogene 19: 3811-3815, 2000.
3. Bates RC, Lincz LF, and Burns GF. Involvement of integrins in cell survival. Cancer Metastasis Rev 14: 191-203, 1995.
4. Belkin AM and Koteliansky VE. Interaction of iodinated vinculin, metavinculin and α-actinin with cytoskeletal proteins. FEBS Lett 220: 291-294, 1987.
5. Bucaro MA, Fertala J, Adams CS, Steinbeck M, Ayyaswamy P, Mukundakrishnan K, Shapiro IM, and Risbud MV. Bone cell survival in microgravity: evidence that modeled microgravity increases osteoblast sensitivity to apoptogens. Ann NY Acad Sci 1027: 64-73, 2004.
6. Chen G and Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science 296: 1634-1635, 2002.
7. Christerson LB, Vanderbilt CA, and Cobb MH. MEKK1 interacts with α-actinin and localizes to stress fibers and focal adhesions. Cell Motil Cytoskeleton 43: 186-198, 1999.
8. Crawford AW, Michelsen JW, and Beckerle MC. An interaction between zyxin and α-actinin. J Cell Biol 116: 1381-1393, 1992.
9. Fandy TE and Srivastava RK. Trichostatin A sensitizes TRAIL-resistant myeloma cells by downregulation of the antiapoptotic Bcl-2 proteins. Cancer Chemother Pharmacol: 1-7, 2006.
10. Faraldo MM, Deugnier MA, Thiery JP, and Glukhova MA. Growth defects induced by perturbation of β1-integrin function in the mammary gland epithelium result from a lack of MAPK activation via the Shc and Akt pathways. EMBO Rep 2: 431-437, 2001.
11. Finlay D, Healy V, Furlong F, O'Connell FC, Keon NK, and Martin F. MAP kinase pathway signalling is essential for extracellular matrix determined mammary epithelial cell survival. Cell Death Differ 7: 302-313, 2000.
12. Flusberg DA, Numaguchi Y, and Ingber DE. Cooperative control of Akt phosphorylation, bcl-2 expression, and apoptosis by cytoskeletal microfilaments and microtubules in capillary endothelial cells. Mol Biol Cell 12: 3087-3094, 2001.
13. Frisch SM and Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124: 619-626, 1994.
14. Frisch SM and Ruoslahti E. Integrins and anoikis. Curr Opin Cell Biol 9: 701-706, 1997.
15. Frisch SM, Vuori K, Kelaita D, and Sicks S. A role for Jun-N-terminal kinase in anoikis; suppression by bcl-2 and crmA. J Cell Biol 135: 1377-1382, 1996.
16. Funakoshi-Tago M, Sonoda Y, Tanaka S, Hashimoto K, Tago K, Tominaga S, and Kasahara T. Tumor necrosis factor-induced nuclear factor κB activation is impaired in focal adhesion kinase-deficient fibroblasts. J Biol Chem 278: 29359-29365, 2003.
17. Glasgow JN, Qiu J, Rassin D, Grafe M, Wood T, and Perez-Pol JR. Transcriptional regulation of the BCL-X gene by NF-κB is an element of hypoxic responses in the rat brain. Neurochem Res 26: 647-659, 2001.
18. Izaguirre G, Aguirre L, Hu YP, Lee HY, Schlaepfer DD, Aneskievich BJ, and Haimovich B. The cytoskeletal/non-muscle isoform of alphaactinin is phosphorylated on its actin-binding domain by the focal adhesion kinase. J Biol Chem 276: 28676-28685, 2001.
19. Jackson ME, Shalhoub V, Lian JB, Stein GS, and Marks SC Jr. Aberrant gene expression in cultured mammalian bone cells demonstrates an osteoblast defect in osteopetrosis. J Cell Biochem 55: 366-372, 1994.
20. Jalali S, del Pozo MA, Chen K, Miao H, Li Y, Schwartz MA, Shyy JY, and Chien S. Integrin-mediated mechanotransduction requires its dynamic interaction with specific extracellular matrix (ECM) ligands. Proc Natl Acad Sci USA 98: 1042-1046, 2001.
21. Jilka RL, Weinstein RS, Bellido T, Parfitt AM, and Manolagas SC. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res 13: 793-802., 1998.
22. Lai CF and Cheng SL. αvβ Integrins play an essential role in BMP-2 induction of osteoblast differentiation. J Bone Miner Res 20: 330-340, 2005.
23. Leinweber BD, Leavis PC, Grabarek Z, Wang CL, and Morgan KG. Extracellular regulated kinase (ERK) interaction with actin and the calponin homology (CH) domain of actin-binding proteins. Biochem J 344: 117-123, 1999.
24. Leskinen MJ, Heikkila HM, Speer MY, Hakala JK, Laine M, Kovanen PT, and Lindstedt KA. Mast cell chymase induces smooth muscle cell apoptosis by disrupting NF-κB-mediated survival signaling. Exp Cell Res 312: 1289-1298, 2006.
25. Martin SS and Vuori K. Regulation of Bcl-2 proteins during anoikis and amorphosis. Biochim Biophys Acta 1692: 145-157, 2004.
26. Meerovitch K, Bergeron F, Leblond L, Grouix B, Poirier C, Bubenik M, Chan L, Gourdeau H, Bowlin T, and Attardo G. A novel RGD antagonist that targets both αvβ3 and α5β1 induces apoptosis of angiogenic endothelial cells on type I collagen. Vascul Pharmacol 40: 77-89, 2003.
27. Nanes MS. Tumor necrosis factor-α: molecular and cellular mechanisms in skeletal pathology. Gene 321: 1-15, 2003.
28. Otey CA and Carpen O. α-Actinin revisited: a fresh look at an old player. Cell Motil Cytoskeleton 58: 104-111, 2004.
29. Otey CA, Pavalko FM, and Burridge K. An interaction between α-actinin and the β1 integrin subunit in vitro. J Cell Biol 111: 721-729, 1990.
30. Parast MM and Otey CA. Characterization of palladin, a novel protein localized to stress fibers and cell adhesions. J Cell Biol 150: 643-656, 2000.
31. Pavalko FM and Burridge K. Disruption of the actin cytoskeleton after microinjection of proteolytic fragments of alpha-actinin. J Cell Biol 114: 481-491, 1991.
32. Pavalko FM, Otey CA, Simon KO, and Burridge K. α-Actinin: a direct link between actin and integrins. Biochem Soc Trans 19: 1065-1069, 1991.
33. Pettersson M, Jernberg-Wiklund H, Larsson LG, Sundstrom C, Givol I, Tsujimoto Y, and Nilsson K. Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells. Blood 79: 495-502, 1992.
34. Pomies P, Louis HA, and Beckerle MC. CRP1, a LIM domain protein implicated in muscle differentiation, interacts with α-actinin. J Cell Biol 139: 157-168, 1997.
35. Ponik SM and Pavalko FM. Formation of focal adhesions on fibronectin promotes fluid shear stress induction of COX-2 and PGE2 release in MC3T3-E1 osteoblasts. J Appl Physiol 97: 135-142, 2004.
36. Raisz LG. Physiology and pathophysiology of bone remodeling. Clin Chem 45: 1353-1358, 1999.
37. Raisz LG and Rodan GA. Pathogenesis of osteoporosis. Endocrinol Metab Clin North Am 32: 15-24, 2003.
38. FAK) and paxillin tyrosine phosphorylation in Swiss 3T3 cells. Bell-shaped dose response and cross-talk with bombesin. J Biol Chem 269: 704-710, 1994.
39. Ray S, Bucur O, and Almasan A. Sensitization of prostate carcinoma cells to Apo2L/TRAIL by a Bcl-2 family protein inhibitor. Apoptosis 10: 1411-1418, 2005.
40. Rodan G, Reszka A, Golub E, and Rizzoli R. Bone safety of long-term bisphosphonate treatment. Curr Med Res Opin 20: 1291-1300, 2004.
41. Sheffield JB, Graff D, and Li HP. A solid-phase method for the quantitation of protein in the presence of sodium dodecyl sulfate and other interfering substances. Anal Biochem 166: 49-54, 1987.
42. Strasser A, Puthalakath H, Bouillet P, Huang DC, O'Connor L, O'Reilly LA, Cullen L, Cory S, and Adams JM. The role of bim, a proapoptotic BH3-only member of the Bcl-2 family in cell-death control. Ann NY Acad Sci 917: 541-548, 2000.
43. Stupack DG and Cheresh DA. Get a ligand, get a life: integrins, signaling and cell survival. J Cell Sci 115: 3729-3738, 2002.
44. Stupack DG, Puente XS, Boutsaboualoy S, Storgard CM, and Cheresh DA. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J Cell Biol 155: 459-470, 2001.
45. Sturgill TW, Ray LB, Erikson E, and Maller JL. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 334: 715-718, 1988.
46. Sun Z and Andersson R. NF-κB activation and inhibition: a review. Shock 18: 99-106, 2002.
47. Tai YT, Podar K, Catley L, Tseng YH, Akiyama M, Shringarpure R, Burger R, Hideshima T, Chauhan D, Mitsiades N, Richardson P, Munshi NC, Kahn CR, Mitsiades C, and Anderson KC. Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of β1-integrin and phosphatidylinositol 3′-kinase/AKT signaling. Cancer Res 63: 5850-5858, 2003.
48. Tamatani M, Che YH, Matsuzaki H, Ogawa S, Okado H, Miyake S, Mizuno T, and Tohyama M. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFκB activation in primary hippocampal neurons. J Biol Chem 274: 8531-8538, 1999.
49. Triplett JW, Herring BP, and Pavalko FM. Adenoviral transgene expression enhanced by cotreatment with etoposide in cultured cells. Biotechniques 39: 826, 828, 830, passim, 2005.
50. Wehrle-Haller B and Imhof B. The inner lives of focal adhesions. Trends Cell Biol 12: 382-389, 2002.
51. Wolff J. Das Gesetz der Transformation der Knochen. Berlin: Hirschwald, 1892.
52. Xia H, Nho RS, Kahm J, Kleidon J, and Henke CA. Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a β1 integrin viability signaling pathway. J Biol Chem 279: 33024-33034, 2004.
53. Zeisel MB, Druet VA, Sibilia J, Klein JP, Quesniaux V, and Wachsmann D. Cross talk between MyD88 and focal adhesion kinase pathways. J Immunol 174: 7393-7397, 2005.
54. Zhang HM, Keledjian KM, Rao JN, Zou T, Liu L, Marasa BS, Wang SR, Ru L, Strauch ED, and Wang JY. Induced focal adhesion kinase expression suppresses apoptosis by activating NF-κB signaling in intestinal epithelial cells. Am J Physiol Cell Physiol 290: C1310-C1320, 2006.
55. Zhang Z, Vuori K, Reed JC, and Ruoslahti E. The α5β 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci USA 92: 6161-6165, 1995.
56. Zong WX, Edelstein LC, Chen C, Bash J, and Gelinas C. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes Dev 13: 382-387, 1999.